Is the era of prostate-specific antigen over?

被引：1
作者：
Djavan, Bob
Rocco, Bernardo
Stangelberger, Anton
De Cobelli, Ottavio
Marberger, Michael
机构：
[1] Univ Vienna, Dept Urol, Vienna, Austria
[2] European Inst Oncol, Div Urol, Milan, Italy
来源：
BJU INTERNATIONAL | 2007年 / 100卷
关键词：
SECTION ROTTERDAM; CANCER; POPULATION; PROGRESSION; NG/ML; MEN; PSA; SERUM; RISK; LESS;
D O I：
10.1111/j.1464-410X.2007.06944.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 27 条
[1]   Early stage prostate cancer - Do we have a problem with over-detection, overtreatment or both? [J].
Carroll, PR .
JOURNAL OF UROLOGY, 2005, 173 (04) :1061-1062
[2]   MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
DODDS, KM ;
COPLEN, DE ;
YUAN, JJJ ;
PETROS, JA ;
ANDRIOLE, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161
[3]  
CATALONA WJ, 2005, ANN M AM UR ASS SAN
[4]   Role of diet in prostate cancer development and progression [J].
Chan, JM ;
Gann, PH ;
Giovannucci, EL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8152-8160
[5]   Time trends in clinical risk stratification for prostate cancer: Implications for outcomes (data from CaPSURE) [J].
Cooperberg, MR ;
Lubeck, DP ;
Mehta, SS ;
Carroll, PR .
JOURNAL OF UROLOGY, 2003, 170 (06) :S21-S25
[6]   Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: Results from the cooperative prostate cancer tissue resource [J].
Datta, MW ;
Dhir, R ;
Dobbin, K ;
Bosland, MC ;
Melamed, J ;
Becich, MJ ;
Orenstein, JM ;
Kajdacsy-Balla, AA ;
Patel, A ;
Macias, V ;
Berman, JJ .
JOURNAL OF UROLOGY, 2005, 173 (05) :1546-1551
[7]   Are repeat biopsies required in men with PSA levels ≤4 ng/ml? -: A multi institutional prospective European study [J].
Djavan, B ;
Fong, YK ;
Ravery, V ;
Remzi, M ;
Horninger, W ;
Susani, M ;
Kreuzer, S ;
Boccon-Gibod, L ;
Bartsch, G ;
Marberger, M .
EUROPEAN UROLOGY, 2005, 47 (01) :38-44
[8]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
[9]   The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy [J].
Freedland, SJ ;
Mangold, LA ;
Walsh, PC ;
Partin, AW .
JOURNAL OF UROLOGY, 2005, 174 (04) :1276-1281
[10]   Population screening and patient testing using PSA [J].
Gray, JAM .
BJU INTERNATIONAL, 2005, 95 :I-I
123